Chembio Diagnostics shares jump 200% on $28.3m order
Chembio Diagnostics shares jump 200% on $28.3m order
By Chris Wack
克里斯·瓦克(Chris Wack)著
Chembio Diagnostics Inc. shares nearly doubled to $4.03 in premarket trading after the company said it received a $28.3 million purchase order from Bio-Manguinhos for Chembio's DPP SARS-CoV-2 antigen tests for delivery during 2021.
Chembio Diagnostics Inc.的股价在盘前交易中几乎翻了一番，至4.03美元，此前该公司表示，它收到了Bio-Manguinhos价值2,830万美元的订单，将于2021年交付Chembio的DPP SARS-CoV-2抗原检测。
Chembio Diagnostics Inc's stock price continues to soar during trading hours on Wednesday
Chembio Diagnostics Inc.的股价在周三的交易时段继续飙升
The company said its antigen test is designed to detect the SARS-CoV-2 antigen, which indicates an active positive test result, in 20 minutes using a minimally invasive nasal swab.
该公司表示，其抗原检测旨在使用微创鼻拭子在20分钟内检测出SARS-CoV-2抗原，这表明检测结果为积极阳性。
Bio-Manguinhos, a subsidiary of the Oswaldo Cruz Foundation, is responsible for the development and production of vaccines, diagnostics, and biopharmaceuticals, primarily to meet demands of Brazil's national public health system.
Bio-Manguinhos是奥斯瓦尔多·克鲁斯基金会(Oswaldo Cruz Foundation)的子公司，负责疫苗、诊断和生物制药的开发和生产，主要是为了满足巴西国家公共卫生系统的需求。
Write to Chris Wack at chris.wack@wsj.com
写信给克里斯·瓦克(chris.wack@wsj.com)
(END) Dow Jones Newswires
(完)道琼通讯社
July 21, 2021 09:24 ET (13:24 GMT)
2021年7月21日09：24美国东部时间(格林尼治标准时间13：24)
Copyright (c) 2021 Dow Jones & Company, Inc.
版权所有(C)2021年道琼斯公司